REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,242 | $14,728 | 1.18% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,978,000 | $17,262,586 | 0.72% |
| Graham Capital Management, L.P. | 31,929,000 | $25,650,931 | 0.60% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $4,034,417 | 0.55% |
| SSI INVESTMENT MANAGEMENT LLC | 6,877,000 | $5,527,733 | 0.45% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 20,000,000 | $16,176,767 | 0.41% |
| Nuveen Asset Management, LLC | 14,000,000 | $1,125,320,000 | 0.40% |
| CSS LLC/IL | 6,052,000 | $4,885,744 | 0.32% |
| Sonora Investment Management Group, LLC | 3,150,000 | $2,551,142 | 0.22% |
| READYSTATE ASSET MANAGEMENT LP | 5,000,000 | $4,044,000 | 0.20% |